Healthcare Industry News: MRI-guided radiotherapy
News Release - March 20, 2012
ViewRay Names Michael Brandt Senior Vice President of Sales
Appointment of Industry Veteran Anticipates Next Stage of MRI-guided radiotherapy TechnologyCLEVELAND, March 20, 2012 -- (Healthcare Sales & Marketing Network) -- ViewRay™ Incorporated, a privately held medical device company, today announced the addition of Michael Brandt as senior vice president of sales. A veteran of the radiation therapy and medical imaging industries, Brandt will lay the groundwork for ViewRay's worldwide sales and marketing programs as the company prepares for the commercialization of its MRI-guided radiotherapy system. ViewRay's treatment planning and delivery software received 510(k) premarket notification clearance from the U.S. FDA in 2011, and its integrated imaging and radiotherapy delivery system is now pending 510(k) review. The ViewRay system is currently available only as a non-human use research system.
"Michael's extensive experience in the radiotherapy and imaging industry makes him a tremendous addition to ViewRay as we prepare for the next stage of the company's development," said ViewRay President and CEO Gregory M. Ayers, MD, PhD. "We are very pleased to have his expertise on the ViewRay executive team."
Brandt brings a strong track record of managing sales, service and marketing of medical capital equipment, including MRI, CT and robotic radiosurgery. Prior to joining ViewRay, he served as general manager of Accuray's Americas division, where he acted as the commercial lead for the acquisition of TomoTherapy, and general manager of the company's Europe, Middle East, India and Africa (EMEIA) division, where he directed the growth of Accuray International. Brandt has also held a variety of international management positions at Philips Medical Systems. At ViewRay, he will oversee the company's business development initiatives and, ultimately, its sales and marketing efforts.
ViewRay holds the exclusive worldwide license for its patented combination of MRI and radiation therapy technologies. Research partners include the University of California, Los Angeles (UCLA) Health System, the University of Wisconsin Carbone Cancer Center, and the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, where the first ViewRay research system is currently being installed.
About ViewRay
ViewRay Incorporated of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. The ViewRay system is being designed to provide continuous soft-tissue imaging during treatment, using MRI-guided radiotherapy, so that clinicians will be able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. For more information, visit http://www.viewray.com.
ViewRay is a trademark of ViewRay Incorporated.
ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.
Source: ViewRay
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
